Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants. - Wikidata - wikimedia - TriplyDB

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

http://www.wikidata.org/entity/Q37578947

about

Provider training and experience for people living with HIV/AIDS Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature Antiretroviral therapy response among HIV-2 infected patients: a systematic review Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.A missing piece in the puzzle: HIV in mature adults in sub-Saharan Africa Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort Study The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study The experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy.Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia.Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique.Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies Distance from home to study clinic and risk of follow-up interruption in a cohort of HIV-1-discordant couples in Nairobi, Kenya.Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.

P2860

Q24236582-AFD2AFDF-D5E1-464A-BDFA-C4F3C647C660 Q26828045-EFA0E7E7-6319-4BD1-9E60-7DD872597B3E Q27003854-E9183CC1-97A9-45B5-BD1C-1D7D659A3DAB Q27022927-AD300B7E-5866-44B2-93F7-FFD0D488411D Q28068815-9622E2FB-1937-401D-BF9D-FF21C064847A Q28475790-A521737E-7352-49E6-9B8E-32501AEE34B6 Q28476337-660470C0-B460-4BD6-966B-EDB229A88D65 Q28540264-8B3B9E6F-4E2B-43EF-887B-3170042D49EC Q30528513-D1EB3559-056F-4A55-BB10-8C2EA4407C0E Q30583563-BB9E2D9A-66DA-49D6-A7DF-AF09C0D26200 Q31020587-FFB6ADC8-61E5-4B7E-B64A-BE18F30125F6 Q33353214-4998DEB4-20E5-4004-83F9-FE0410C836BF Q33479343-295F3FBE-E911-4489-AA83-6955740A39EA Q33590533-A5FCB374-7599-4B1F-B5B9-B4683DF1433D Q33596118-B3405694-63AF-4560-9B36-20EC017ABED0 Q33618976-36E84709-7E2C-4222-B943-747AC190DC95 Q33619740-518145FF-F921-40F5-96FB-46254F0F860F Q33625803-724E8D2C-0F86-43D7-BD3D-7480D32DBAE3 Q33638969-9DAB5701-6DCF-4E69-81F6-E76549848DC9 Q33648147-AEFEA197-E01F-4279-BE39-7EA7A456CA8B Q33670735-32B15E80-2D0A-4B94-84B1-389E10157EE1 Q33718364-86925A43-C902-4405-8BEB-AC9C79963814 Q33770158-FBBBED3D-3C45-42E6-A3FC-305C05539CE7 Q33787607-77E048E5-3787-43FD-8D53-271D9B43FB85 Q33869315-927738FE-F307-485F-995E-C655EC35249A Q33889133-A56EAE72-3A97-42CF-B441-D2EF4B893A63 Q33891896-2C36C7AF-5DFD-4AA7-BE5F-7E9BBB5A90BE Q33958103-C54CAA01-E886-4392-97DF-FD7C75D7F8E9 Q33965572-8DA4E47B-45CB-4524-8EED-537859C47336 Q34019508-D7A6C1D0-24EC-4222-9C82-A01B3213F7FA Q34040005-6161B659-6B04-44CF-B91E-34E6D76982FE Q34056071-648603E9-1054-409A-9475-F48079545008 Q34056735-9B433526-7BBA-4BAF-A5B8-50973BA1780A Q34097961-5C13C00E-CE14-4DC8-92E5-7B4C1B910DB7 Q34119037-43FF2B5A-2777-4489-828A-88E86DE0EFD7 Q34148314-EE75287B-4AA0-4819-A9FF-2B983F951010 Q34155253-6DC58E07-251F-4A5B-AFB4-2ADD5250DDD0 Q34398967-B1A36090-C420-4798-8C58-AF5EA52E7C47 Q34503222-9A5C0265-A542-4FE8-86AD-AC9F2CDCDBBF Q34556999-61A7FA7E-780C-46B6-90DF-C96E7FA326E1

P2860

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

http://www.wikidata.org/entity/Q37578947

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@en

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@nl

type

label

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@en

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@nl

prefLabel

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@en

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@nl

P1433

Q37578947-69B87673-5234-44B7-9ECE-AA379A9B02A4

P1476

Q37578947-2E55CC9C-F110-4EF3-9B76-494CA948C600

P2093

Q37578947-03FF64D6-25F6-4ADF-8F17-4B5874955FCA

Q37578947-37B8C57F-C67A-4F7B-9CEA-6B360B34DE31

Q37578947-622CC1AB-F699-4839-86AD-7965863F0790

Q37578947-750F474B-6C9A-442E-8121-A64B635F2405

Q37578947-82FB1078-2FC1-4BC6-9047-D7EF2C2C0DCB

Q37578947-852C4058-AE93-421A-8625-3E4F3C016B64

Q37578947-B4660453-02F5-4DFD-A793-9A66F001489C

Q37578947-C118826E-9141-42C5-843D-23E9FBAA47DC

Q37578947-DF6163EC-E014-4A54-A627-E3A5F6AB0B62

Q37578947-EC598923-E7D7-4422-B919-60562FE82579

P2860

Q37578947-0BC8CF38-EBCF-4142-B5C0-6AC53EBFE7E2

Q37578947-0DBF297D-E1AE-4D55-A292-A84AEBFA0B28

Q37578947-172642B5-C7BA-474F-85D6-D7DE4201CFB8

Q37578947-19ADBBAA-3A16-4BE9-BF6F-0BCDDED09E3F

Q37578947-2956641A-3F7F-4323-89AC-20EB07464E37

Q37578947-29A16811-F166-4133-BB33-7A561EF707AF

Q37578947-2C914A44-64C7-48A8-9F45-96235D2D92BD

Q37578947-3B23C408-2004-4697-8D89-24383EB354E6

Q37578947-3B876FF3-C104-45DB-8167-C1F56AD8C92E

Q37578947-3E1E1978-BC2E-4211-B07B-755AF6101412

P304

Q37578947-589DD6F7-41D8-46AD-AF76-381B83E5E8AA

P31

Q37578947-944C3326-BFBC-492D-B3E4-E9F9E1800264

P356

Q37578947-C05CEB25-53C6-4E8C-BA4D-9B2EDFCBEAD2

P407

Q37578947-19EA6C93-96C1-47B0-AABA-6640B5026284

P433

Q37578947-7D5F18BC-2360-411C-9A5C-6F28769ADE7E

P478

Q37578947-57B5CB7D-C80F-4224-950D-39559E0AFF5B

P50

Q37578947-402A2ADA-D03C-4A0A-8FAB-0E7C00E6CB75

Q37578947-5EC041BB-983C-44FB-B134-F54BC4671746

P577

Q37578947-1F933F60-AC72-4A89-ACC2-882DA70C65AC

P698

Q37578947-1E0D7C22-F38A-4BF0-9AB2-196AC3FE9C37

P921

Q37578947-53E60D86-73FF-4718-843B-142656C93DF1

Q37578947-A5C3F5EB-A411-4854-A05B-D66E6C226F74

P932

Q37578947-1F3E668E-0E1C-4533-A8AC-1DFD4A3C5C91

P356

QAD.0B013E3282F768F8

P1433

P1476

Rapid scaling-up of antiretrov ...... ear outcomes and determinants.

@en

P2093

Aconda Study Group

http://www.w3.org/2001/XMLSchema#string

Bertin Kouadio

http://www.w3.org/2001/XMLSchema#string

Catherine Seyler

http://www.w3.org/2001/XMLSchema#string

Christophe Grundmann

http://www.w3.org/2001/XMLSchema#string

Julien Duvignac

http://www.w3.org/2001/XMLSchema#string

Moussa Traore

http://www.w3.org/2001/XMLSchema#string

Nafissatou Diakite

http://www.w3.org/2001/XMLSchema#string

Nicole Dakoury-Dogbo

http://www.w3.org/2001/XMLSchema#string

Richard Marlink

http://www.w3.org/2001/XMLSchema#string

Siaka Toure

http://www.w3.org/2001/XMLSchema#string

P2860

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women.

Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa.

Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

P304

873-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E3282F768F8

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

François Dabis

Xavier Anglaret

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18427206

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3921665

http://www.w3.org/2001/XMLSchema#string